The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Trial (FUN)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01543789 |
Recruitment Status
: Unknown
Verified June 2015 by University Hospital, Ghent.
Recruitment status was: Recruiting
First Posted
: March 5, 2012
Last Update Posted
: June 3, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The use of mesh in the repair of umbilical hernias is a gold standard. The best location of the mesh remains a matter of discussion, i.e. it might be placed inside the peritoneal cavity (open intraperitoneal onlay mesh) or between the peritoneum and the muscle layers, so not in contact with the viscera (retromuscular or preperitoneal). The Rebound mesh consists of polypropylene, i.e. the most used fabric for meshes, in combination with a nitinol memory ring. This ring allows the surgeon to position the mesh more flat, with less wrinkling and subsequently better tissue ingrowth. It also saves time for both patient's anesthesia and the surgery.
This type of mesh (one coated with PTFE for intra-abdominal use and one pure polypropylene for preperitoneal use), will be used in this multicentric trial, to evaluate the best procedure in terms of efficacy, safety and postoperative complications.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Umbilical Hernia | Procedure: Intraperitoneal mesh placement Procedure: Preperitoneal mesh placement | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Randomized Controlled Trial. |
Study Start Date : | March 2012 |
Estimated Primary Completion Date : | December 2015 |
Estimated Study Completion Date : | March 2016 |

Arm | Intervention/treatment |
---|---|
Experimental: Intraperitoneal mesh placement
Mesh placement inside the peritoneal cavity
|
Procedure: Intraperitoneal mesh placement
Mesh placement inside the peritoneal cavity.
|
Active Comparator: Preperitoneal mesh placement
Mesh placement between peritoneum and muscle layer.
|
Procedure: Preperitoneal mesh placement
Mesh placement between peritoneum and muscle layer.
|
- Operation time between preperitoneal mesh placement versus intraperitoneal mesh placement. [ Time Frame: Total duration of the operation with an expected average of approximately 45 minutes. ]Time registration of the operating time will be extracted from the hospital electronic patient files.
- Surgical wound morbidity complication rate. [ Time Frame: Up to 1 year. ]
- Recurrence Rate [ Time Frame: up to 2 years ]Clinical examination will be performed. No ultrasound, unless doubt about recurrence.
- Pain evaluation [ Time Frame: within 2 weeks prior to surgery, after 4 weeks, after 1 year and after 2 years ]A questionnaire and Visual Analog Scale (VAS) will be filled out. The patient is asked whether he or she has pain. Answer NO: VAS = 0, Yes: patient will determine the exact VAS score.
- Discomfort evaluation. [ Time Frame: Within 2 weeks prior to surgery, after 4 weeks, after 1 year and after 2 years. ]A questionnaire and Visual Analog Scale (VAS) will be filled out. The patient is asked whether he or she has discomfort. Answer NO: VAS = 0, Yes: patient will determine the exact VAS score.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- written informed consent from the patient or his/her legal representative
- primary umbilical hernia requiring elective surgical repair
- diameter between 0 and 3 cm
Exclusion Criteria:
- no written informed consent
- incisional hernia at the level of the umbilicus
- recurrent umbilical hernia, as they have to be considered an incisional hernia
- emergency surgery (incarcerated hernia)
- pregnancy
- non-compliance

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01543789
Contact: Frederik Berrevoet, MD, PhD | Frederik.Berrevoet@ugent.be | ||
Contact: Aude Vanlander, MD | Aude.Vanlander@ugent.be |
Belgium | |
ASZ Aalst | Recruiting |
Aalst, Belgium, 9300 | |
Contact: Tijl Vierendeels, MD Tijl.Vierendeels@asz.be | |
Principal Investigator: Tijl Vierendeels, MD | |
Ghent University Hospital | Recruiting |
Ghent, Belgium, 9000 | |
Contact: Frederik Berrevoet, MD, PhD Frederik.Berrevoet@ugent.be | |
Principal Investigator: Frederik Berrevoet, MD, PhD | |
UZ Leuven | Recruiting |
Leuven, Belgium, 3000 | |
Contact: Marc Miserez, MD, PhD marc.miserez@uz.kuleuven.ac.be | |
Principal Investigator: Marc Miserez, MD, PhD |
Principal Investigator: | Frederik Berrevoet, MD, PhD | University Hospital, Ghent |
Additional Information:
Responsible Party: | University Hospital, Ghent |
ClinicalTrials.gov Identifier: | NCT01543789 History of Changes |
Other Study ID Numbers: |
EC/2012/072 |
First Posted: | March 5, 2012 Key Record Dates |
Last Update Posted: | June 3, 2015 |
Last Verified: | June 2015 |
Keywords provided by University Hospital, Ghent:
Umbilical Hernia |
Additional relevant MeSH terms:
Hernia Hernia, Umbilical Pathological Conditions, Anatomical |
Infant, Newborn, Diseases Hernia, Ventral Hernia, Abdominal |